SEC Company Response from AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Jul 20, 2017

AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: July 20, 2017 · CIK: 0001460702 · Accession: 0001493152-17-008037

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

July 20, 2017

Author

Chief

Form

CORRESP

Company

AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)

Letter

Ritter Pharmaceuticals, Inc.

Century Park East, Suite 1000

Los Angeles, CA 90067

(310) 203-1000

July 20, 2017

VIA EDGAR

United States Securities and Exchange Commission

F Street, NE

Washington, D.C. 20549

Attention: Chris Edwards and Suzanne Hayesa

Re:

Ritter Pharmaceuticals, Inc. – Withdrawal of Acceleration Request

Registration Statement on Form S-1

File No. 333- 219147

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on July 20, 2017, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday, July 20, 2017, at 5:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

RITTER PHARMACEUTICALS, INC.

By: /s/ Michael D. Step

Michael D. Step

Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

Ritter
Pharmaceuticals, Inc.

1880
Century Park East, Suite 1000

Los
Angeles, CA 90067

(310)
203-1000

July
20, 2017

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, NE

Washington,
D.C. 20549

Attention:
Chris Edwards and Suzanne Hayesa

    Re:

    Ritter
    Pharmaceuticals, Inc. – Withdrawal of Acceleration Request

    Registration
    Statement on Form S-1

    File
    No. 333- 219147

Ladies
and Gentlemen:

Reference
is made to our letter, filed as correspondence via EDGAR on July 20, 2017, in which we requested the acceleration of the effective
date of the above-referenced Registration Statement for Thursday, July 20, 2017, at 5:00 p.m. Eastern Time, in accordance with
Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared
effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

    RITTER
    PHARMACEUTICALS, INC.

    By:
    /s/
Michael D. Step

    Michael
        D. Step

        Chief
        Executive Officer

SecProbe.io